Analysis of prognostic factors in patients with brain metastases affecting survival

Analysis of prognostic factors in patients with brain metastases affecting survival

Abstract Introduction Brain metastases (BM) are associated with dismal prognosis as they cause significant morbidity and affect the quality of life of patients. Management of BM depends on the following factors: age, patient performance, size and the number of lesions, location of the tumor, comorbi...

Full description

Bibliographic Details
Main Authors:	Sweety Gupta, Sumit Singh, Atokali Chophy, Sharanya Nair, Rachit Ahuja, K. Kusum, Deepa Joseph, Rajnish Arora, Amit Gupta, Manoj Gupta
Format:	Article
Language:	English
Published:	SpringerOpen 2022-11-01
Series:	Journal of the Egyptian National Cancer Institute
Subjects:	Metastases Brain Whole brain radiotherapy Survival
Online Access:	https://doi.org/10.1186/s43046-022-00146-z

Similar Items

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies
by: Dorien E.C.M. de Vocht, et al.
Published: (2023-09-01)

Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies
by: Valeria Internò, et al.
Published: (2023-02-01)

Editorial: Effects of radiation therapies on brain metastases
by: Rupesh Kotecha, et al.
Published: (2023-04-01)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
by: Dirk Rades, et al.
Published: (2023-04-01)

Salvage Treatment for Progressive Brain Metastases in Breast Cancer
by: Mateusz Jacek Spałek, et al.
Published: (2022-02-01)

Unilateral hippocampal sparing during whole brain radiotherapy for multiple brain metastases: narrative and critical review
by: Petr Pospisil, et al.
Published: (2024-01-01)

Role of DOSE Escalation in whole Brain Radiotherapy for Brain Metastasis in Patients with a Favorable Survival Prognosis
by: Saroj Dhaka, et al.
Published: (2022-02-01)

The First Survival Score for Patients Aged ≥80 Years Irradiated for Brain Metastases
by: Dirk Rades, et al.
Published: (2022-09-01)

Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center
by: Bolanle Adegboyega, et al.
Published: (2023-12-01)

Hippocampal sparing in whole-brain radiotherapy for brain metastases: controversy, technology and the future
by: Rui Liu, et al.
Published: (2024-01-01)

Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient Profiles
by: Nicolas G. Nelson, et al.
Published: (2024-03-01)

Selecting the Appropriate Radiation Therapy Technique for Extensive Brain Metastases from Tens to Hundreds: Should the Latest Technique Always Be the Best Option?
by: Seok Ho Lee
Published: (2023-10-01)

Survival and effective prognostic factors in lung cancer patients with brain metastases treated with whole brain radiotherapy
by: Bixin Ren, et al.
Published: (2021-03-01)

Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
by: Su Zhou, et al.
Published: (2023-03-01)

A modified melanoma-molGPA scoring model: assessment of survival after and efficacy of different radiotherapy modalities in patients with melanoma brain metastases
by: Qian Wu, et al.
Published: (2023-06-01)

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death
by: Cherel Pascal, et al.
Published: (2011-09-01)

Evaluation of Whole Brain Radiotherapy among Lung Cancer Patients with Brain Metastases in Relation to Health Care Level and Survival
by: Gabriella Frisk, et al.
Published: (2022-04-01)

Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study
by: Rebecca Rootwelt Winther, et al.
Published: (2023-06-01)

Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases
by: Yu Wang, et al.
Published: (2023-09-01)

Frequency of metastases within the hypothalamic–pituitary area and the associated high-risk factors in patients with brain metastases
by: Peng Xie, et al.
Published: (2023-11-01)

Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases
by: Zhengting Chen, et al.
Published: (2022-09-01)

Fractionated Stereotactic Radiotherapy with Helical Tomotherapy for Brain Metastases: A Mono-Institutional Experience
by: Francesco Cuccia, et al.
Published: (2023-07-01)

Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature
by: Georg Feldmann, et al.
Published: (2013-04-01)

Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model
by: Kyrhatii Trikhirhisthit, et al.
Published: (2022-11-01)

Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy
by: Yi‐Chun Hua, et al.
Published: (2023-11-01)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
by: Benoît Calderon, et al.
Published: (2023-07-01)

Local treatment of breast cancer brain metastases
by: Ana Magličić, et al.
Published: (2022-01-01)

Stereotactic radiosurgery of brain metastases: a retrospective study
by: Isabella Gruber, et al.
Published: (2023-12-01)

Validation and discussion of clinical practicability of the 2022 graded prognostic assessment for NSCLC adenocarcinoma patients with brain metastases in a routine clinical cohort
by: C. Schröder, et al.
Published: (2023-03-01)

Prediction of Prognostic Factors in the Survival of Non-small-cell Lung Cancer Patients with Multiple Brain Metastases
by: Özlem Mermut, et al.
Published: (2021-02-01)

The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery
by: David M. Routman, et al.
Published: (2018-03-01)

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment
by: Cheng Kong, et al.
Published: (2023-09-01)

Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis Factors
by: Lun Liang, et al.
Published: (2023-02-01)

Extrathoracic Metastases in Pleural Mesothelioma
by: Ibiayi Dagogo-Jack, MD, et al.
Published: (2023-09-01)

Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02)
by: Claire Phillips, et al.
Published: (2024-04-01)

Prognostic value of cell-free DNA in cerebrospinal fluid from lung cancer patients with brain metastases during radiotherapy
by: Simiao Qiao, et al.
Published: (2023-03-01)

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
by: Olivier J. van Not, et al.
Published: (2023-05-01)

Use of helical TomoTherapy (HT) for the focal hypofractionated treatment of limited brain metastases in the initial and recurrent setting.
by: Andrew eElson, et al.
Published: (2015-02-01)

Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade
by: Jorge Avila, et al.
Published: (2024-03-01)

Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control
by: Toshimichi Nakano, et al.
Published: (2022-11-01)